| A brief review of nutraceutical ingredients in gastrointestinal disorders: Evidence and suggestions X Gao, J Liu, L Li, W Liu, M Sun International journal of molecular sciences 21 (5), 1822, 2020 | 27 | 2020 |
| Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt R Sun, L Zhu, L Li, W Song, X Gong, X Qi, Y Wang, R Ghose, S Gao, M Hu, ... Toxicology and applied pharmacology 398, 115032, 2020 | 24 | 2020 |
| Simultaneous determinations of 17 marker compounds in Xiao–Chai–Hu–Tang by LC–MS/MS: Application to its pharmacokinetic studies in mice R Sun, M Zeng, T Du, L Li, G Yang, M Hu, S Gao Journal of Chromatography B 1003, 12-21, 2015 | 19 | 2015 |
| Pharmacokinetic and Metabolic Profiling of Key Active Components of Dietary Supplement Magnolia officinalis Extract for Prevention against Oral Carcinoma D Bui, L Li, T Yin, X Wang, S Gao, M You, R Singh, M Hu Journal of agricultural and food chemistry 68 (24), 6576-6587, 2020 | 18 | 2020 |
| Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3, 5-diphenyl-2-aminopyridine scaffold C Suebsuwong, B Dai, DM Pinkas, AL Duddupudi, L Li, JC Bufton, ... European journal of medicinal chemistry 200, 112417, 2020 | 16 | 2020 |
| A novel strategy for screening bioavailable quality markers of traditional Chinese medicine by integrating intestinal absorption and network pharmacology: Application to Wu Ji … S Duan, L Niu, T Yin, L Li, S Gao, D Yuan, M Hu Phytomedicine 76, 153226, 2020 | 14 | 2020 |
| One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging L Xie, R Li, B Zheng, Z Xie, X Fang, T Dai, X Wang, L Li, L Wang, ... ACS Applied Bio Materials 4 (3), 2723-2731, 2021 | 13 | 2021 |
| Using Tiny-TIM Dissolution and In Silico Simulation to Accelerate Oral Product Development of a BCS Class II Compound L Luo, NK Thakral, R Schwabe, L Li, S Chen AAPS PharmSciTech 23 (6), 1-10, 2022 | 11 | 2022 |
| Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan’s Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced Diarrhea R Sun, S Basu, M Zeng, R Sunsong, L Li, R Ghose, W Wang, Z Liu, M Hu, ... Current cancer drug targets 19 (7), 551-560, 2019 | 11 | 2019 |
| Development and validation of an LC-MS/MS method for the quantification of flavonoid glucuronides (wogonoside, baicalin, and apigenin-glucuronide) in the bile and blood samples … Y Tu, L Zhou, L Li, L Wang, S Gao, M Hu Analytical biochemistry 601, 113723, 2020 | 10 | 2020 |
| Design and synthesis of a novel nir celecoxib-based fluorescent probe for cyclooxygenase-2 targeted bioimaging in tumor cells X Wang, L Wang, L Xie, Z Xie, L Li, D Bui, T Yin, S Gao, M Hu Molecules 25 (18), 4037, 2020 | 9 | 2020 |
| Development and validation of ultra‐high‐performance liquid chromatography–mass spectrometry method for the determination of raloxifene and its phase II metabolites in plasma … T Du, R Sun, L Li, C Ebuzoeme, D Bui, Z Zheng, T Yin, D Liang, M Hu, ... Journal of Separation Science 43 (24), 4414-4423, 2020 | 8 | 2020 |
| Irinotecan decreases intestinal UDP-glucuronosyltransferase (UGT) 1A1 via TLR4/MyD88 pathway prior to the onset of diarrhea G Tao, F Dagher, L Li, R Singh, M Hu, R Ghose Food and Chemical Toxicology 166, 113246, 2022 | 7 | 2022 |
| Prediction of in vivo supersaturation and precipitation of poorly water-soluble drugs: achievements and aspirations NK Thakral, E Meister, C Jankovsky, L Li, R Schwabe, L Luo, S Chen International Journal of Pharmaceutics 600, 120505, 2021 | 7 | 2021 |
| Acute changes in colonic PGE 2 levels as a biomarker of efficacy after treatment of the Pirc (F344/NTac-Apc am1137) rat with celecoxib C Yun, WM Dashwood, L Li, T Yin, AM Ulusan, K Shatzer, S Gao, ... Inflammation Research 69 (1), 131-137, 2020 | 7 | 2020 |
| Comparison of Absolute Expression and Turnover Number of COX-1 and COX-2 in Human and Rodent Cells and Tissues L Li, R Sun, J Zenga, H Himburg, L Wang, S Duan, J Liu, D Bui, Z Xie, ... Journal of Inflammation Research 15, 4435, 2022 | 4 | 2022 |
| Development of a physiologically based pharmacokinetic model to predict irinotecan disposition during inflammation G Tao, PK Chityala, L Li, Z Lin, R Ghose Chemico-Biological Interactions 360, 109946, 2022 | 2 | 2022 |
| Optimized rat models better mimic patients with irinotecan-induced severe diarrhea Z Zheng, T Du, S Gao, T Yin, L Li, L Zhu, R Singh, R Sun, M Hu Toxicology Mechanisms and Methods, 1-12, 2024 | | 2024 |
| Intestinal Perfusion Methods for Oral Drug Absorptions L Li, D Bui, W Zhu, EJ Jeong Oral Bioavailability and Drug Delivery: From Basics to Advanced Concepts and …, 2023 | | 2023 |
| Herbal Medicines as Adjuvants for the Treatment of Chemotherapy-Induced Diarrhea Z Zheng, S Srinual, J Chen, L Li, T Du, M Hu, R Sun, S Gao Current Drug Metabolism 24 (6), 422-433, 2023 | | 2023 |
